Form 4 for BFRI Biofrontera Inc.
Accepted 2026-07-29 17:47:43 ET · period of report 2026-07-28 · accession 0001493152-26-035273 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-29 17:47 | 2026-07-28 | BFRI | Luebbert Hermann | CEO, COB, Dir | M - OptEx | — | +62.5K | 352.7K | +22% | — |
| D | 2026-07-29 17:47 | 2026-07-28 | BFRI | Luebbert Hermann | CEO, COB, Dir | M - OptEx | $0.00 | -62.5K | 62.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-28 | M | A | 62,500 | — | 352,711 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 2. The Company elected to convert the restricted stock units into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2026-07-28 | M | D | 62,500 | $0.00 | 62,500 | D | — · — to — | 62,500 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 2. The Company elected to convert the restricted stock units into common stock on a one-for-one basis. (F2) On July 22, 2025, the Reporting Person was granted 125,000 restricted stock units, vesting in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date. (F2) On July 22, 2025, the Reporting Person was granted 125,000 restricted stock units, vesting in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date. (F3) Restricted stock units with different terms are not included. |